Last updated on December 2019

Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads


Brief description of study

The QP ExCELs study is designed to confirm safety and efficacy of the BIOTRONIK Sentus OTW QP left ventricular leads to satisfy FDA requirements for regulatory approval of the leads in the US. The Sentus OTW QP leads received FDA approval on May 4, 2017.

Long-term safety of the BIOTRONIK Sentus OTW QP left ventricular leads will be confirmed during the ongoing post approval phase (US sites only).

Clinical Study Identifier: NCT02290028

Find a site near you

Start Over